Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorder
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Common variable immunodeficiency disorders (CVIDs) are the most frequent symptomatic primary immune deficiency condition in adults. The genetic basis for the condition is not known and no single clinical feature or laboratory test can establish the diagnosis; it has been a diagnosis of exclusion. In areas of uncertainty, diagnostic criteria can provide valuable clinical information. Here, we compare the revised European society of immune deficiencies (ESID) registry (2014) criteria with the diagnostic criteria of Ameratunga et al. (2013) and the original ESID/pan American group for immune deficiency (ESID/PAGID 1999) criteria. The ESID/PAGID (1999) criteria either require absent isohemagglutinins or impaired vaccine responses to establish the diagnosis in patients with primary hypogammaglobulinemia. Although commonly encountered, infective and autoimmune sequelae of CVID were not part of the original ESID/PAGID (1999) criteria. Also excluded were a series of characteristic laboratory and histological abnormalities, which are useful when making the diagnosis. The diagnostic criteria of Ameratunga et al. (2013) for CVID are based on these markers. The revised ESID registry (2014) criteria for CVID require the presence of symptoms as well as laboratory abnormalities to establish the diagnosis. Once validated, criteria for CVID will improve diagnostic precision and will result in more equitable and judicious use of intravenous or subcutaneous immunoglobulin therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients
Cunningham-Rundles, C., & Bodian, C. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4725 · Cited by 1,516 · cited 7×
“Male or female patient who has a marked decrease (at least 2 SD below the mean for age) in at least one of the major isotypes (IgM, IgG, and IgA) and fulfils all of the following criteria: 1.”
BackgroundInfluentialPicard, C., Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Conley, M. E., Cunningham-Rundles, C., Etzioni, A., Holland, S. M., Klein, C., et al. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0201-1 · Cited by 1,197
Diagnostic Criteria for Primary Immunodeficiencies
Conley, M. E., Notarangelo, L. D., & Etzioni, A. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4799 · Cited by 1,042
The EUROclass trial: defining subgroups in common variable immunodeficiency
Wehr, C., Kivioja, T., Schmitt, C., Ferry, B., Witte, T., Eren, E., Vlkova, M., Hernandez, M., Detkova, D., Bos, P. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-091744 · Cited by 859 · cited 4×
“increased CD21 low subsets by flow cytometry (9)”
BackgroundInfluentialCommon variable immunodeficiency disorders: division into distinct clinical phenotypes
Chapel, H., Lucas, M., Lee, M., Bjorkander, J., Webster, D., Grimbacher, B., Fieschi, C., Thon, V., Abedi, M. R., & Hammarstrom, L. (2008) · Blood · doi:10.1182/blood-2007-11-124545 · Cited by 835
Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Conley, M. E., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Gaspar, H. B., Holland, S. M., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00162 · Cited by 748
Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency
Grimbacher, B., Hutloff, A., Schlesier, M., Glocker, E., Warnatz, K., Dräger, R., Eibel, H., Fischer, B., Schäffer, A. A., Mages, H. W., et al. (2003) · Nature Immunology · doi:10.1038/ni902 · Cited by 733
Clinical picture and treatment of 2212 patients with common variable immunodeficiency
Gathmann, B., Mahlaoui, N., Gérard, L., Oksenhendler, E., Warnatz, K., Schulze, I., Kindle, G., Kuijpers, T. W., van Beem, R. T., Guzman, D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1077 · Cited by 634 · cited 2×
“This was illustrated in recent CVID studies, where there were wide variations in complications leading to different clinical phenotypes as well as bronchiectasis in countries within the European Union as well as the United States (4, 7, 69).”
BackgroundPrimary hypogammaglobulinaemia: a survey of clinical manifestations and complications
Hermaszewski, R. A., & WEBSTER, A. D. B. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068735 · Cited by 567
An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene
van Zelm, M. C., Reisli, I., van der Burg, M., Castaño, D., van Noesel, C. J. M., van Tol, M. J. D., Woellner, C., Grimbacher, B., Patiño, P. J., van Dongen, J. J. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051568 · Cited by 540
Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency
QUINTI, I., SORESINA, A., SPADARO, G., MARTINO, S., DONNANNO, S., AGOSTINI, C., CLAUDIO, P., FRANCO, D., MARIA PESCE, A., BORGHESE, F., et al. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9075-1 · Cited by 536
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Bernstein, I. L., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Kobrynski, L. J., Levinson, A. I., Mazer, B., Nelson, R. P., et al. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61142-8 · Cited by 521 · cited 2×
“Diagnostic criteria have not been defined: at least five different criteria in the literature (64, 65)”
BackgroundInfections in 252 Patients with Common Variable Immunodeficiency
Oksenhendler, E., Gérard, L., Fieschi, C., Malphettes, M., Mouillot, G., Jaussaud, R., Viallard, J., Gardembas, M., Galicier, L., Schleinitz, N., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587669 · Cited by 477 · cited 3×
“The majority of adult patients with CVID have IgG levels below 5 g/l (5).”
BackgroundMethodInfluentialOrange, J. S., Ballow, M., Stiehm, E. R., Ballas, Z. K., Chinen, J., De La Morena, M., Kumararatne, D., Harville, T. O., Hesterberg, P., Koleilat, M., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.002 · Cited by 456 · cited 4×
“However, there have been concerns about risks associated with the rabies vaccine (54) and the typhoid vaccine is not yet widely used.”
BackgroundInfluentialLucas, M., Lee, M., Lortan, J., Lopez-Granados, E., Misbah, S., & Chapel, H. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.040 · Cited by 443 · cited 1×
“It will be important to offer IVIG/SCIG for patients with bronchiectasis with higher levels of IgG for example (sHGUS) (76).”
BackgroundJódar, L., Butler, J., Carlone, G., Dagan, R., Goldblatt, D., Käyhty, H., Klugman, K., Plikaytis, B., Siber, G., Kohberger, R., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00230-5 · Cited by 388
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
van Zelm, M. C., Smet, J., Adams, B., Mascart, F., Schandené, L., Janssen, F., Ferster, A., Kuo, C.-C., Levy, S., van Dongen, J. J. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39748 · Cited by 381
CD20 deficiency in humans results in impaired T cell–independent antibody responses
Kuijpers, T. W., Bende, R. J., Baars, P. A., Grummels, A., Derks, I. A. M., Dolman, K. M., Beaumont, T., Tedder, T. F., van Noesel, C. J. M., Eldering, E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40231 · Cited by 375
Malamut, G., Verkarre, V., Suarez, F., Viallard, J.-F., Lascaux, A.-S., Cosnes, J., Bouhnik, Y., Lambotte, O., Béchade, D., Ziol, M., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.214 · Cited by 297 · cited 1×
“• Absence of plasma cells on gut biopsy (17, 18)”
BackgroundConcepcion, N. F., & Frasch, C. E. (2001) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.2.266-272.2001 · Cited by 287 · cited 1×
“Cross-reactive carbohydrates can interfere with the assay (57, 58)”
BackgroundSalzer, U., Bacchelli, C., Buckridge, S., Pan-Hammarström, Q., Jennings, S., Lougaris, V., Bergbreiter, A., Hagena, T., Birmelin, J., Plebani, A., et al. (2009) · Blood · doi:10.1182/blood-2008-02-141937 · Cited by 285
IPINet Investigators, Quinti, I., Soresina, A., Guerra, A., Rondelli, R., Spadaro, G., Agostini, C., Milito, C., Trombetta, A. C., Visentini, M., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9511-0 · Cited by 270 · cited 1×
“IVIG/SCIG treatment can substantially improve both quality of life (20) and longevity in patients with CVID.”
BackgroundPan-Hammarström, Q., Salzer, U., Du, L., Björkander, J., Cunningham-Rundles, C., Nelson, D. L., Bacchelli, C., Gaspar, H. B., Offer, S., Behrens, T. W., et al. (2007) · Nature Genetics · doi:10.1038/ng0407-429 · Cited by 233
Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases
Ochs, H. D., Davis, S. D., & Wedgwood, R. J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106756 · Cited by 219 · cited 2×
“The ψx174 vaccine has not been registered by the FDA and cannot be used in routine clinical practice (67).”
BackgroundO'Brien, K. L., Hochman, M., & Goldblatt, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70210-4 · Cited by 213 · cited 4×
“PPV is administered to test response to T-cell independent carbohydrate antigens, while conjugated vaccines such as HIB and toxoids test responses to T-cell dependent antigens.”
BackgroundInfluentialAl-Herz, W. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00054 · Cited by 194 · cited 1×
“If identified by molecular diagnostic studies (39), these patients are, however, no longer classified as having CVID and are removed from further consideration of the disorder (40, 41).”
BackgroundGenome-wide association identifies diverse causes of common variable immunodeficiency
Orange, J. S., Glessner, J. T., Resnick, E., Sullivan, K. E., Lucas, M., Ferry, B., Kim, C. E., Hou, C., Wang, F., Chiavacci, R., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.039 · Cited by 192
Malamut, G., Ziol, M., Suarez, F., Beaugrand, M., Viallard, J. F., Lascaux, A. S., Verkarre, V., Bechade, D., Poynard, T., Hermine, O., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.011 · Cited by 188 · cited 1×
“• Nodular regenerative hyperplasia of the liver (14, 15)”
BackgroundMusher, D. M., Manoff, S. B., Liss, C., McFetridge, R. D., Marchese, R. D., Bushnell, B., Alvarez, F. B., Painter, C., Blum, M. D., & Silber, J. L. (2010) · The Journal of Infectious Diseases · doi:10.1086/649839 · Cited by 161
“A Rose is a Rose is a Rose,” but CVID is Not CVID
Yong, P. F. K., Thaventhiran, J. E. D., & Grimbacher, B. (2011) · Advances in immunology · doi:10.1016/b978-0-12-385991-4.00002-7 · Cited by 160 · cited 1×
“Several eminent authors have expressed concern about the need for revised diagnostic criteria for CVID (70, 71).”
BackgroundAgarwal, S., Smereka, P. N., Harpaz, N., Cunningham‐Rundles, C., & Mayer, L. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21376 · Cited by 139 · cited 1×
“• Absence of plasma cells on gut biopsy (17, 18)”
BackgroundAssessment and clinical interpretation of reduced IgG values
Agarwal, S., & Cunningham-Rundles, C. (2007) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60665-5 · Cited by 126 · cited 2×
“There is general agreement with the third ESID/PAGID (1999) criterion that other secondary causes of hypogammaglobulinemia including drug-induced disorders need to be excluded (22, 44, 45).”
BackgroundResultHenckaerts, I., Goldblatt, D., Ashton, L., & POOLMAN, J. T. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.3.356-360.2006 · Cited by 115 · cited 1×
“Cross-reactive carbohydrates can interfere with the assay (57, 58)”
BackgroundJokinen, J., Åhman, H., Kilpi, T. M., Mäkelä, P. H., & Käyhty, M. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/422531 · Cited by 106 · cited 1×
“Mucosal protection may require higher antibody levels cf sepsis (63)”
BackgroundActive vaccination in patients with common variable immunodeficiency (CVID)
Goldacker, S., Draeger, R., Warnatz, K., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.04.011 · Cited by 99 · cited 9×
“In contrast to the revised ESID registry (2014) criteria, the Ameratunga et al. (2013) criteria require vaccine responses to be compared to the normal population, as a significant proportion of presumed CVID patients have protective antibody responses to tetanus and Pneumovax® (48, 49).”
BackgroundInfluentialCorrelates of immunity for pneumococcal conjugate vaccines
Lee, L. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00025-2 · Cited by 90
Ritchie, R. F., Palomaki, G. E., Neveux, L. M., Navolotskaia, O., Ledue, T. B., & Craig, W. Y. (1998) · Journal of Clinical Laboratory Analysis · Cited by 71 · cited 1×
“5th percentile, as immunoglobulin levels are not normally distributed (34)], as well as impaired vaccine challenge responses or absent isohemagglutinins and other secondary causes of hypogammaglobulinemia were to be excluded.”
BackgroundWeller, E. B., Weller, R. A., & Dogin, J. W. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00180-3 · Cited by 67
Perspectives on common variable immune deficiency
Park, J. H., Resnick, E. S., & Cunningham‐Rundles, C. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06338.x · Cited by 66 · cited 1×
“CVID is likely to represent a heterogeneous group of polygenic disorders (6).”
BackgroundGrabenstein, J. D., & Manoff, S. B. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.052 · Cited by 60 · cited 1×
“Adequate but transient vaccine responses are also included in category C criteria (21, 29).”
BackgroundDuraisingham, S., Buckland, M. S., Grigoriadou, S., & Longhurst, H. J. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.902314 · Cited by 52
The effect of age on the response to the pneumococcal polysaccharide vaccine
Lee, H., Nahm, M. H., & Kim, K.-H. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-60 · Cited by 51 · cited 1×
“Differences in responses between middle aged and elderly adults (55)”
BackgroundRezaei, N., Siadat, S. D., Aghamohammadi, A., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00389-09 · Cited by 37
Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?
Seppänen, M. R. J., Aghamohammadi, A., & Rezaei, N. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.870478 · Cited by 37 · cited 1×
“Several eminent authors have expressed concern about the need for revised diagnostic criteria for CVID (70, 71).”
BackgroundAmeratunga, R., Woon, S., Neas, K. R., & Love, D. R. (2010) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-6-12 · Cited by 33
Self-citationLamotrigine-induced common variable immune deficiency
Smith, J., Fernando, T., McGrath, N., & Ameratunga, R. (2004) · Neurology · doi:10.1212/01.wnl.0000113754.29225.5d · Cited by 30 · cited 2×
“There is general agreement with the third ESID/PAGID (1999) criterion that other secondary causes of hypogammaglobulinemia including drug-induced disorders need to be excluded (22, 44, 45).”
BackgroundResultSelf-citationHaemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009
Ladhani, S. N., Ramsay, M. E., Flood, J. S., Campbell, H., Slack, M., Pebody, R. G., Findlow, J., Newton, E., Wilding, M. R., Warrington, R., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.46.20313-en · Cited by 25
Ameratunga, R., Woon, S., Brewerton, M., Koopmans, W., Jordan, A., Brothers, S., & Singh, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06238.x · Cited by 23 · cited 1×
“If identified by molecular diagnostic studies (39), these patients are, however, no longer classified as having CVID and are removed from further consideration of the disorder (40, 41).”
BackgroundSelf-citation
Cited by
British Thoracic Society Guideline for bronchiectasis in adults
T Hill, A., L Sullivan, A., D Chalmers, J., De Soyza, A., Stuart Elborn, J., Andres Floto, R., Grillo, L., Gruffydd-Jones, K., Harvey, A., S Haworth, C., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212463 · Cited by 617
Gut Microbiota–Host Interactions in Inborn Errors of Immunity
Castagnoli, R., Pala, F., Bosticardo, M., Licari, A., Delmonte, O. M., Villa, A., Marseglia, G. L., & Notarangelo, L. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031416 · Cited by 34
“Common variable immunodeficiency (CVID) is a clinically heterogeneous primary immunodeficiency characterized by hypogammaglobulinemia and impaired antibody responses to vaccine antigens [112,113].”
Background
Metadata
- Authors
- Ameratunga, R., Brewerton, M., Slade, C., Jordan, A., Gillis, D., Steele, R., Koopmans, W., & Woon, S.-T.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014-09-15
- Volume
- 5
- Pages
- 415-415
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2117544288
- Cited by
- 161
- References
- 48
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.